Author

Seifeldin Awad

Beth Israel Deaconess Medical CenterORCID 0000-0002-1787-6696Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Carla CalaguaiD· 2 shared David Johnson EinsteiniD· 2 shared Olga S. VoznesenskyiD· 2 shared Steven P. BalkiD· 2 shared Adam G. SowalskyiD· 1 shared Alex TokeriD· 1 shared Anson T. KuiD· 1 shared Betul Ersoy-FazliogluiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Carla CalaguaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 30, 2026

Higher T-cell density in primary prostate cancer is associated with reduced fraction of CD8 effector cells and increased TIGIT

Seifeldin Awad, Carla Calagua, Olga S. Voznesensky…·Steven P. Balk

The paper examines immune infiltration in prostate cancer, finding higher T-cell density correlates with reduced CD8 effector cells and increased TIGIT, suggesting immune suppression.

DOI 10.64898/2026.08.27.747524

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedOct 2, 2025

Androgen deprivation-mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Fen Ma, Sen Chen, Luigi Giovanni Cecchi…·Steven P. Balk

This study shows that in prostate cancer with TMPRSS2:ERG fusion, androgen deprivation increases AKT activation, which may reduce the effectiveness of AR-targeted therapy, suggesting combination therapy could be beneficial.

4 citations

mousehuman

𝕏 PostBluesky